Uh-Oh Labs COVID-19 instrument gets authorized by the FDA

We got amazing news from our client Uh-Oh Labs! ๐ŸŽ‰ย  The team have announced they recently received FDA authorization (EUA) for their UOL COVID-19 instrument developed in collaboration with NOVO.

The UOL COVID-19 Test has been designed to allow for simple testing, accurate results, and a lower per-test cost compared to other COVID molecular diagnostics.

Our team specifically contributed to the design of the main UOL instrument that allows convenient testing and data transfer to the Uh-Oh Labs Dx Pro App. NOVO provided expertise in user experience, industrial design, software and firmware development, mechanical and electronic engineering.

Uh-Ohโ€™s powerful technology has been supported with over $15M in contracts from the National Institutes of Health as well as investments from private investors such as Y Combinator.

We can’t wait to see their next achievements! Kudos to Cameron Ball and the entire team! ๐Ÿ‘

Stay tuned for a future case study on how we worked with Uh-Oh Labs to develop this innovative device for effective COVID-19 testing.

Let's co-create your project.

Our product experts can help you bring your innovation to market.

What to read next

NOVO 2022 Wrap-Up

Cybersecurity and connected medical devices: best practices to limit the risks

Subscribe to our Monthly Digest

You can unsubscribe at any time.

We want to offer content that truly matters to you.

By browsing this site, you accept the general terms of use and the use of cookies.